Doctors FDA Approval Hormones 
The Pharma Data
DECEMBER 18, 2020
FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Food and Drug Administration (FDA) has approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer. BASEL, Switzerland, Dec. Indication.
XTalks
NOVEMBER 9, 2022
Since Mounjaro’s May US Food and Drug Administration (FDA) approval, sales of the drug have skyrocketed beyond initial expectations owing to patient demand and a temporary shortage of Novo’s Ozempic. Mounjaro and Ozempic are both FDA approved for glycemic control in adults with type 2 diabetes, in combination with diet and exercise.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
AUGUST 17, 2021
If your doctor decides to give your child any insulin products, he or she may give you special instructions. Do not change the type of insulin you take or your dose, unless your doctor tells you to. If you are at risk of having severely low blood sugar, your doctor may prescribe a glucagon emergency kit. Before using.
pharmaphorum
OCTOBER 26, 2022
Food and Drug Administration approved Vtama (tapinarof) cream, an aryl hydrocarbon receptor agonist and the first FDA-approved steroid-free topical medication in its class. Two months later, Arcutis won approval for its Zoryve (roflumilast) cream. When this hormone is suppressed, response to stressors (e.g.
The Pharma Data
SEPTEMBER 1, 2021
The FDA approval of INVEGA HAFYERA™ is based on the results of a 12-month, randomized, double-blind, non-inferiority Phase 3 global study that enrolled 702 adults (ages 18-70) living with schizophrenia from 20 countries. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
pharmaphorum
AUGUST 8, 2022
Bayer has won a key FDA approval to extend the use of its prostate cancer therapy Nubeqa, as it tries to claim market share from rival drugs and fulfil its aim of building the drug into a €3 billion ($3.1 billion) blockbuster. Most men with mHSPC will eventually progress to CRPC, which has poor survival prospects.
The Pharma Data
MAY 13, 2021
Well, sleep keeps the “hunger hormones” (ghrelin and leptin) in check. When you don’t get enough sleep, you create an imbalance between these hormones and that leads to an increased appetite which, in turn, will put your weight loss journey to a halt. Well, sleep keeps the “hunger hormones” (ghrelin and leptin) in check.
Expert insights. Personalized for you.
52 
Let's personalize your content